Prospective evaluation of coronavirus disease 2019 (COVID-19) vaccine responses across a broad spectrum of immunocompromising conditions: the COVID-19 …

…, MD Crandall, MD Sobolewksi… - Clinical Infectious …, 2022 - academic.oup.com
Background We studied humoral responses after coronavirus disease 2019 (COVID-19)
vaccination across varying causes of immunodeficiency. Methods Prospective study of fully …

Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

FR Simonetti, MD Sobolewski, E Fyne… - Proceedings of the …, 2016 - National Acad Sciences
Reservoirs of infectious HIV-1 persist despite years of combination antiretroviral therapy and
make curing HIV-1 infections a major challenge. Most of the proviral DNA resides in CD4 + …

Immunogenicity of COVID-19 vaccination in immunocompromised patients: an observational, prospective cohort study interim analysis

…, DK McMahon, M Crandall, PN Enick, M Sobolewksi… - MedRxiv, 2021 - medrxiv.org
Objectives Immunocompromised patients were excluded from COVID-19 vaccine clinical
trials. The objectives of the study were to measure antibody responses, levels, and …

[HTML][HTML] SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization

…, S Zhou, KS Tuttle, MD Sobolewski… - Nature …, 2022 - nature.com
Mutations in the spike glycoproteins of SARS-CoV-2 variants of concern have independently
been shown to enhance aspects of spike protein fitness. Here, we describe an antibody …

Fenugreek: a naturally occurring edible spice as an anticancer agent

S Shabbeer, M Sobolewski, RK Anchoori… - Cancer biology & …, 2009 - Taylor & Francis
In recent years, various dietary components that can potentially be used for the prevention
and treatment of cancer have been identified. In this study, we demonstrate that extract (FE) …

Intractable coronavirus disease 2019 (COVID-19) and prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in a chimeric antigen …

…, B Staines, A Heaps, MD Sobolewski… - Clinical Infectious …, 2021 - academic.oup.com
A chimeric antigen receptor-modified T-cell therapy recipient developed severe coronavirus
disease 2019, intractable RNAemia, and viral replication lasting >2 months. Premortem …

Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines

A Pledgie-Tracy, MD Sobolewski, NE Davidson - Molecular cancer …, 2007 - AACR
Sulforaphane, an isothiocyanate found in cruciferous vegetables, has been shown to induce
phase 2 detoxication enzymes and inhibit the growth of chemically induced mammary …

Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

AR Cillo, MD Sobolewski, RJ Bosch… - Proceedings of the …, 2014 - National Acad Sciences
Reversal of proviral latency is being pursued as a curative strategy for HIV-1 infection.
Recent clinical studies of in vivo administration of the histone deacetylase inhibitor …

[HTML][HTML] Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

JK Bui, MD Sobolewski, BF Keele, J Spindler… - PLoS …, 2017 - journals.plos.org
The major obstacle to curing HIV infection is the persistence of cells with intact proviruses that
can produce replication-competent virus. This HIV reservoir is believed to exist primarily in …

Naive CD4+ T cells harbor a large inducible reservoir of latent, replication-competent human immunodeficiency virus type 1

…, DK McMahon, MD Sobolewski… - Clinical Infectious …, 2019 - academic.oup.com
Background The latent human immunodeficiency virus type 1 (HIV-1) reservoir represents a
major barrier to a cure. Based on the levels of HIV-1 DNA in naive (T N ) vs resting memory …